top of page
Search

May 1, 2019 - Experimental Treatment Could Be "Game-Changing" For Inherited ALS

  • Writer: Center for Neurologic Study
    Center for Neurologic Study
  • Nov 10, 2020
  • 1 min read

The results of a Phase 2 trial using a drug strategy pioneered by our director, Richard Smith M.D., in collaboration with Ionis Pharmaceuticals and the University of California, San Diego has been reported to demonstrate promising results in a Biogen-sponsored treatment trial. Click here for more information.


Recent Posts

See All

Comments


© 2021 by Center for Neurologic Study.

bottom of page